Your browser doesn't support javascript.
loading
Catalyst-Controlled C-H Allylation and Annulation of 2-Aryl Quinazolinones with 2-Methylidene Cyclic Carbonate.
Ko, Nayoung; Min, Sujin; Moon, Kyeongwon; Shin, Hyungjin; Kwon, Na Yeon; Mishra, Neeraj Kumar; Rakshit, Amitava; Singh, Pargat; Kim, In Su.
Afiliação
  • Ko N; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Min S; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Moon K; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Shin H; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Kwon NY; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Mishra NK; Department of Chemistry, University of Lucknow, Lucknow 226007, India.
  • Rakshit A; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Singh P; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Kim IS; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
J Org Chem ; 88(18): 13315-13326, 2023 Sep 15.
Article em En | MEDLINE | ID: mdl-37668242
The site-selective modification of quinazolinone as a privileged bicyclic N-heterocycle is an attractive topic in medicinal chemistry and material science. We herein report the ruthenium(II)-catalyzed C-H allylation of 2-aryl quinazolinones with 2-methylidene cyclic carbonate. In addition, tandem C-H allylation and annulation are achieved under rhodium(III) catalysis, resulting in the formation of tetracyclic quinazolinones including a tertiary carbon center. Post-transformations of the synthesized products demonstrate the potential of the developed methodology. A series of mechanistic investigations were also performed.

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Org Chem Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Org Chem Ano de publicação: 2023 Tipo de documento: Article